Global Health
Medical Care Facilities · MEDANTA
Large CapHealthcareHigh Growth
Dr. Naresh Kumar Trehan
Chairman and Managing Director · Transformational
Company DNA
Founder-Centric
About
Global Health is a Large Cap company in the Healthcare sector, listed on NSE as MEDANTA. With a market cap of ₹29K Cr and revenue of ₹4K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Strong influence of Dr. Naresh Trehan on the medical vision and operational oversight. Its strategic mandate: Continued growth requires rapid scaling of hospital infrastructure and clinical footprints across new high-potential geographies.
FAQ
What kind of company is Global Health?
Global Health is a Large Cap Healthcare company (MEDANTA) in the High Growth phase with a market cap of ₹29K Cr. It is classified as Founder-Centric in culture.
What is Global Health's culture and work environment like?
Global Health has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Talent Magnet. Customer relationship style: Premium-Niche. Strong influence of Dr. Naresh Trehan on the medical vision and operational oversight.
Who leads Global Health?
Global Health is led by Dr. Naresh Kumar Trehan (Chairman and Managing Director), a Transformational leader with 57 years of experience.
What are Global Health's financials?
Global Health reported revenue of ₹4K Cr in FY25 with a 5-year revenue CAGR of 18.8%. Operating margin: 20.3%. Market cap: ₹29K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerPremium-Niche
EmployeeTalent Magnet
BrandTechnical-Expert
LifecycleHigh Growth
Strong influence of Dr. Naresh Trehan on the medical vision and operational oversight.
Mandate
Continued growth requires rapid scaling of hospital infrastructure and clinical footprints across new high-potential geographies.
Continued growth requires rapid scaling of hospital infrastructure and clinical footprints across new high-potential geographies.
Financials
Revenue FY25₹4K Cr
PAT FY25₹481 Cr
Rev CAGR 5Y18.8%
OPM20.3%
NPM13.2%
ROE14.2%
ROCE17.8%
P/E56.2
Fwd P/E41.3
P/B7.8
D/E25.5
Mkt Cap₹29K Cr
Promoter67.5%
Institutional21.7%
Similar Culture
Could You Lead Global Health?
Take the Genome Benchmark →